KR20040074362A - Antimicrobial hollow fiber membrane and method of preparing the same - Google Patents
Antimicrobial hollow fiber membrane and method of preparing the same Download PDFInfo
- Publication number
- KR20040074362A KR20040074362A KR1020030009956A KR20030009956A KR20040074362A KR 20040074362 A KR20040074362 A KR 20040074362A KR 1020030009956 A KR1020030009956 A KR 1020030009956A KR 20030009956 A KR20030009956 A KR 20030009956A KR 20040074362 A KR20040074362 A KR 20040074362A
- Authority
- KR
- South Korea
- Prior art keywords
- hollow fiber
- antimicrobial
- fiber membrane
- antimicrobial agent
- organic
- Prior art date
Links
- 239000012528 membrane Substances 0.000 title claims abstract description 98
- 239000012510 hollow fiber Substances 0.000 title claims abstract description 74
- 230000000845 anti-microbial effect Effects 0.000 title claims abstract description 45
- 238000000034 method Methods 0.000 title claims abstract description 11
- 239000004599 antimicrobial Substances 0.000 claims abstract description 69
- 238000004519 manufacturing process Methods 0.000 claims abstract description 24
- 230000000844 anti-bacterial effect Effects 0.000 claims abstract description 15
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims abstract description 10
- 239000000203 mixture Substances 0.000 claims abstract description 10
- 229910021536 Zeolite Inorganic materials 0.000 claims abstract description 8
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 claims abstract description 8
- 239000010457 zeolite Substances 0.000 claims abstract description 8
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 claims abstract description 7
- 229910052709 silver Inorganic materials 0.000 claims abstract description 7
- 239000004332 silver Substances 0.000 claims abstract description 7
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims abstract description 5
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 claims abstract description 5
- 239000000377 silicon dioxide Substances 0.000 claims abstract description 5
- 229910052725 zinc Inorganic materials 0.000 claims abstract description 5
- 239000011701 zinc Substances 0.000 claims abstract description 5
- 229910052801 chlorine Inorganic materials 0.000 claims abstract description 4
- 239000000460 chlorine Substances 0.000 claims abstract description 4
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims abstract description 3
- 239000005749 Copper compound Substances 0.000 claims abstract description 3
- 229910052802 copper Inorganic materials 0.000 claims abstract description 3
- 239000010949 copper Substances 0.000 claims abstract description 3
- 150000001880 copper compounds Chemical class 0.000 claims abstract description 3
- 229960002026 pyrithione Drugs 0.000 claims abstract description 3
- 150000003752 zinc compounds Chemical class 0.000 claims abstract description 3
- 238000001471 micro-filtration Methods 0.000 claims abstract 2
- 238000000108 ultra-filtration Methods 0.000 claims abstract 2
- 238000009987 spinning Methods 0.000 claims description 34
- 230000001112 coagulating effect Effects 0.000 claims description 26
- -1 chlorine phenyl ether compound Chemical class 0.000 claims description 15
- 150000002433 hydrophilic molecules Chemical class 0.000 claims description 10
- 229920001600 hydrophobic polymer Polymers 0.000 claims description 9
- 239000003960 organic solvent Substances 0.000 claims description 8
- 230000005855 radiation Effects 0.000 claims description 7
- 229910052783 alkali metal Inorganic materials 0.000 claims description 4
- 229910052784 alkaline earth metal Inorganic materials 0.000 claims description 4
- 229910021645 metal ion Inorganic materials 0.000 claims description 4
- 239000008399 tap water Substances 0.000 claims description 4
- 235000020679 tap water Nutrition 0.000 claims description 4
- 150000002897 organic nitrogen compounds Chemical class 0.000 claims description 2
- 125000001453 quaternary ammonium group Chemical group 0.000 claims description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 21
- 241000894006 Bacteria Species 0.000 abstract description 4
- 150000001875 compounds Chemical class 0.000 abstract description 4
- GUUULVAMQJLDSY-UHFFFAOYSA-N 4,5-dihydro-1,2-thiazole Chemical compound C1CC=NS1 GUUULVAMQJLDSY-UHFFFAOYSA-N 0.000 abstract description 2
- 230000002401 inhibitory effect Effects 0.000 abstract description 2
- 150000002736 metal compounds Chemical class 0.000 abstract description 2
- FGVVTMRZYROCTH-UHFFFAOYSA-N pyridine-2-thiol N-oxide Chemical compound [O-][N+]1=CC=CC=C1S FGVVTMRZYROCTH-UHFFFAOYSA-N 0.000 abstract description 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 abstract 1
- USIUVYZYUHIAEV-UHFFFAOYSA-N diphenyl ether Chemical compound C=1C=CC=CC=1OC1=CC=CC=C1 USIUVYZYUHIAEV-UHFFFAOYSA-N 0.000 abstract 1
- 125000001477 organic nitrogen group Chemical group 0.000 abstract 1
- 230000000149 penetrating effect Effects 0.000 abstract 1
- 229910052710 silicon Inorganic materials 0.000 abstract 1
- 239000010703 silicon Substances 0.000 abstract 1
- 238000010186 staining Methods 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 28
- 238000005345 coagulation Methods 0.000 description 13
- 230000015271 coagulation Effects 0.000 description 13
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 12
- 230000000052 comparative effect Effects 0.000 description 10
- 229920000642 polymer Polymers 0.000 description 7
- 244000005700 microbiome Species 0.000 description 6
- 230000001186 cumulative effect Effects 0.000 description 5
- 238000001914 filtration Methods 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 239000002245 particle Substances 0.000 description 5
- 229920002492 poly(sulfone) Polymers 0.000 description 5
- 238000002835 absorbance Methods 0.000 description 4
- 239000003242 anti bacterial agent Substances 0.000 description 4
- 229910052751 metal Inorganic materials 0.000 description 4
- 239000002184 metal Substances 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- 239000002202 Polyethylene glycol Substances 0.000 description 3
- 239000000701 coagulant Substances 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000012466 permeate Substances 0.000 description 3
- 229920001223 polyethylene glycol Polymers 0.000 description 3
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 3
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 3
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 3
- PICXIOQBANWBIZ-UHFFFAOYSA-N zinc;1-oxidopyridine-2-thione Chemical compound [Zn+2].[O-]N1C=CC=CC1=S.[O-]N1C=CC=CC1=S PICXIOQBANWBIZ-UHFFFAOYSA-N 0.000 description 3
- DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 2
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 2
- 239000002033 PVDF binder Substances 0.000 description 2
- 239000000853 adhesive Substances 0.000 description 2
- 230000001070 adhesive effect Effects 0.000 description 2
- 239000003146 anticoagulant agent Substances 0.000 description 2
- 229940127219 anticoagulant drug Drugs 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 238000009395 breeding Methods 0.000 description 2
- 230000001488 breeding effect Effects 0.000 description 2
- MVPPADPHJFYWMZ-UHFFFAOYSA-N chlorobenzene Chemical compound ClC1=CC=CC=C1 MVPPADPHJFYWMZ-UHFFFAOYSA-N 0.000 description 2
- 238000005520 cutting process Methods 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 235000019441 ethanol Nutrition 0.000 description 2
- AMXOYNBUYSYVKV-UHFFFAOYSA-M lithium bromide Chemical compound [Li+].[Br-] AMXOYNBUYSYVKV-UHFFFAOYSA-M 0.000 description 2
- RLSSMJSEOOYNOY-UHFFFAOYSA-N m-cresol Chemical compound CC1=CC=CC(O)=C1 RLSSMJSEOOYNOY-UHFFFAOYSA-N 0.000 description 2
- 229920002239 polyacrylonitrile Polymers 0.000 description 2
- 229920000151 polyglycol Polymers 0.000 description 2
- 239000010695 polyglycol Substances 0.000 description 2
- 229920002635 polyurethane Polymers 0.000 description 2
- 239000004814 polyurethane Substances 0.000 description 2
- 229920002981 polyvinylidene fluoride Polymers 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000011550 stock solution Substances 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 238000004804 winding Methods 0.000 description 2
- 229920012266 Poly(ether sulfone) PES Polymers 0.000 description 1
- 239000004695 Polyether sulfone Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 150000002902 organometallic compounds Chemical class 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920006393 polyether sulfone Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D69/00—Semi-permeable membranes for separation processes or apparatus characterised by their form, structure or properties; Manufacturing processes specially adapted therefor
- B01D69/08—Hollow fibre membranes
- B01D69/087—Details relating to the spinning process
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D65/00—Accessories or auxiliary operations, in general, for separation processes or apparatus using semi-permeable membranes
- B01D65/02—Membrane cleaning or sterilisation ; Membrane regeneration
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D65/00—Accessories or auxiliary operations, in general, for separation processes or apparatus using semi-permeable membranes
- B01D65/08—Prevention of membrane fouling or of concentration polarisation
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D67/00—Processes specially adapted for manufacturing semi-permeable membranes for separation processes or apparatus
- B01D67/0002—Organic membrane manufacture
- B01D67/0009—Organic membrane manufacture by phase separation, sol-gel transition, evaporation or solvent quenching
- B01D67/0016—Coagulation
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D69/00—Semi-permeable membranes for separation processes or apparatus characterised by their form, structure or properties; Manufacturing processes specially adapted therefor
- B01D69/08—Hollow fibre membranes
- B01D69/085—Details relating to the spinneret
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F1/00—Treatment of water, waste water, or sewage
- C02F1/44—Treatment of water, waste water, or sewage by dialysis, osmosis or reverse osmosis
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D2323/00—Details relating to membrane preparation
- B01D2323/12—Specific ratios of components used
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D2323/00—Details relating to membrane preparation
- B01D2323/15—Use of additives
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D2325/00—Details relating to properties of membranes
- B01D2325/36—Hydrophilic membranes
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D2325/00—Details relating to properties of membranes
- B01D2325/38—Hydrophobic membranes
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D2325/00—Details relating to properties of membranes
- B01D2325/48—Antimicrobial properties
Landscapes
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Hydrology & Water Resources (AREA)
- Environmental & Geological Engineering (AREA)
- Water Supply & Treatment (AREA)
- Organic Chemistry (AREA)
- Dispersion Chemistry (AREA)
- Manufacturing & Machinery (AREA)
- Separation Using Semi-Permeable Membranes (AREA)
- Artificial Filaments (AREA)
Abstract
Description
본 발명은 중공사 분리막 필터에 있어서 지속적인 항균기능을 가지는 중공사막 및 그의 제조방법에 관한 것이다.The present invention relates to a hollow fiber membrane having a continuous antibacterial function in the hollow fiber membrane filter and a method for manufacturing the same.
중공사막 필터는 그 적용 방식에 따라 부분여과 방식과 전량여과 방식으로 나뉘게 된다. 이중 전량여과 방식은 물의 낭비가 적고, 필터의 구조가 간단하다는 장점이 있는 대신 시간이 지남에 따라 막이 쉽게 오염되므로 수명이 짧아지고 분리성능이 저하되는 단점이 있다. 특히, 공급수에 존재하는 미생물들이 막에 의해 분리된 후 필터의 외부로 배출되지 못하므로, 필터의 공급측과 막외표면에서 번식하여 막의 투과 특성을 떨어뜨리게 된다.Hollow fiber membrane filter is divided into partial filtration and total filtration according to the application method. The dual filtration method has the advantage of low water consumption and simple structure of the filter, but has a disadvantage in that the membrane is easily contaminated over time, thereby shortening the life and degrading separation performance. In particular, since the microorganisms present in the feed water cannot be discharged to the outside of the filter after being separated by the membrane, breeding on the feed side and the outer membrane surface of the filter degrades the permeation characteristics of the membrane.
이를 막기 위해 중공사막 이전에 전처리 필터나 활성탄 층에 항균성을 지닌 은, 세라믹 등의 소재를 사용하여 미생물의 유입을 차단하는 방법 등이 사용되고 있지만, 미생물을 완전히 차단하는 것은 중공사막의 역할이므로, 전처리단계에서는 미생물의 유입을 억제하는 수준밖에 기대할 수 없다.In order to prevent this, a method of blocking microorganisms by using a material such as silver or ceramic having antibacterial effect on the pretreatment filter or activated carbon layer before the hollow fiber membrane is used, but since it is the role of the hollow fiber membrane to completely block the microorganism, In the stage, only the level of inhibiting the introduction of microorganisms can be expected.
또, 일본 공개특허 제98-328659호에서는 일단 유입된 미생물이 번식하지 못하도록 하기 위하여 전량여과식 중공사막 필터에 세정을 위한 추가 유로를 설치하였다. 이 방법은 평상시에는 전량여과 방식으로 정수를 하고, 일정시간마다 별도의 유로를 통해 정수 필터의 외부를 수도물로 세정하는 방식이다.In addition, Japanese Patent Application Laid-Open No. 98-328659 provided an additional flow path for cleaning the whole-filtration hollow fiber membrane filter in order to prevent the microorganisms once introduced from breeding. In this method, water purification is usually performed by total filtration, and the outside of the water filter is washed with tap water through a separate flow path at a predetermined time.
이러한 방법은 필터 외부의 부유물질의 농도를 낮추는데는 효과적이나, 막의 성능을 저하시키는 직접적인 원인인 분리막 표면에 접착되어 있는 미생물의 덩어리 즉, 바이오필름(Biofilm)은 제거할 수 없는 단점이 있다.This method is effective in lowering the concentration of suspended solids outside the filter, but there is a disadvantage in that the mass of microorganisms, that is, biofilm, adhered to the separator surface, which is a direct cause of deterioration of the membrane, cannot be removed.
본 발명은 중공사막 자체에 지속적인 항균성을 부여함으로써, 제균성능과 내오염성이 우수하고, 사용 수명이 연장된, 항균성이 우수한 중공사막을 제공하고자 한다.The present invention is to provide a hollow fiber membrane excellent in antibacterial properties, excellent antibacterial performance and fouling resistance, prolonged service life by imparting continuous antimicrobial properties to the hollow fiber membrane itself.
이와 같은 과제를 달성하기 위한 본 발명의 항균 중공사막은 중공사막 내에 항균제가 함유되어 있으며, 일반 수도수를 5,000L/m2투과 사용한 후 중공사막 내의 잔존 항균제 함량이 초기 함량의 70% 이상인 것을 특징으로 한다.The antimicrobial hollow fiber membrane of the present invention for achieving such a problem is characterized in that the antimicrobial agent is contained in the hollow fiber membrane, the residual antimicrobial agent content in the hollow fiber membrane is 70% or more of the initial content after using 5,000 L / m 2 permeate of general tap water It is done.
또한, 본 발명의 항균 중공사막의 제조방법은 소수성 고분자, 유기용매 및 친수성 화합물로 구성된 방사도프와 내부응고액을 2중 관형노즐로 공기 중으로 방사한 후 외부응고액으로 응고시켜 중공사막을 제조할 때, 상기 방사도프 또는 내부응고액에 항균제를 첨가하는 것을 특징으로 한다.In addition, the method for producing the antimicrobial hollow fiber membrane of the present invention is to produce a hollow fiber membrane by spinning the spinning dope and the internal coagulating solution composed of a hydrophobic polymer, an organic solvent and a hydrophilic compound into the air with a double tubular nozzle and then coagulated with an external coagulating solution. When the antibacterial agent is added to the spinning dope or internal coagulating solution.
이하, 본 발명을 상세하게 설명하기로 한다.Hereinafter, the present invention will be described in detail.
본 발명의 항균 중공사막은 분리막을 형성하는 소수성고분자와 분리막내에 공경(pore)을 형성하고 소수성인 분리막에 잔존하여 친수성을 부여하는 역할을 하는 친수성 화합물, 그리고 항균제로 이루어 진다. 소수성 고분자로서는 폴리설폰계 고분자, 폴리아크릴계 고분자, 폴리카보네이트, 할로겐계 고분자 등이 사용될 수 있다. 좀더 구체적으로는 폴리설폰(Polysulfone), 폴리이써설폰(PES, Polyethersulfone), 폴리아크릴로나트릴(PAN), 폴리비닐리덴플로라이드(PVDF), 폴리테트라플루오로에탄(PTFE) 등이 사용될 수 있다. 친수성 화합물로써는 비닐피롤리돈계 폴리머, 폴리글리콜 등이 사용되는데, 중공사 막 내에 많이 잔존할 수 있도록 분자량이 10,000이상인 것을 사용하는 것이 바람직 하다. 폴리글리콜로는 폴리에틸렌글리콜 또는 폴리비닐알콜 등을 사용하고, 비닐피롤리돈계 폴리머로는 폴리비닐피롤리돈 등을 사용하는 것이 바람직 하다.The antimicrobial hollow fiber membrane of the present invention is composed of a hydrophobic polymer forming a separator, a hydrophilic compound forming a pore in the separator and remaining in the hydrophobic separator to impart hydrophilicity, and an antibacterial agent. As the hydrophobic polymer, polysulfone polymer, polyacrylic polymer, polycarbonate, halogen polymer and the like can be used. More specifically, polysulfone (Polysulfone), polyethersulfone (PES, Polyethersulfone), polyacrylonitrile (PAN), polyvinylidene fluoride (PVDF), polytetrafluoroethane (PTFE) may be used. As the hydrophilic compound, vinylpyrrolidone-based polymers, polyglycols, and the like are used. It is preferable to use those having a molecular weight of 10,000 or more so as to remain much in the hollow fiber membranes. It is preferable to use polyethylene glycol, polyvinyl alcohol, etc. as polyglycol, and polyvinylpyrrolidone etc. as vinylpyrrolidone type polymer.
항균성을 부여하기 위한 항균제로서는 일반적으로 알려져 있는 유기계 항균제 또는 무기계 항균제를 사용할 수 있다. 중공사막에 적용하기 위해서는 막제조공정에서의 안정성, 중공사막 재질과의 상용성, 막의 물성에 미치는 영향, 내구성, 분산성 등을 고려해야 한다As an antimicrobial agent for imparting antimicrobial properties, generally known organic antimicrobial agents or inorganic antimicrobial agents can be used. To be applied to the hollow fiber membrane, the stability in the membrane manufacturing process, compatibility with the material of the hollow fiber membrane, influence on the properties of the membrane, durability, dispersibility, etc. should be considered.
유기계 항균제의 경우, 종류가 많고 효과도 뛰어나지만 안전성(독성, 환경문제)에 문제가 있어 사용이 제한적이다. 특히, 정수용 막에 사용하는 경우는 인체에 무해한 것을 선택 사용하여야 한다. 본 발명에 사용할 수 있는 유기계 항균제로는 유기구리 화합물, 유기아연 화합물, 기타 유기금속 화합물과 염소페닐에테르계 화합물, 유기질소계 화합물, 유기실리콘 제4급 암모늄 등이 있고, 좀더 구체적으로는 하기 일반식(Ⅰ)의 이소티아조린(Isothiazolin)계 화합물, 하기 일반식(Ⅱ)의 피리티온(Pyrithione)계 금속화합물 등이 사용될 수 있다.Organic antimicrobial agents have many types and excellent effects, but have limited use due to problems in safety (toxicity and environmental problems). In particular, when used for the membrane for water purification should be selected to be harmless to the human body. Organic antimicrobial agents that can be used in the present invention include organic copper compounds, organic zinc compounds, other organometallic compounds and chlorine phenyl ether compounds, organic nitrogen compounds, organosilicon quaternary ammonium, and the like, and more specifically, Isothiazolin-based compounds of (I), pyrithione-based metal compounds of the general formula (II) and the like can be used.
(Ⅰ) (Ⅰ)
상기 식(Ⅰ)에서, R1, R2및 R3는 H, Cl 또는 알킬기 이다.In the formula (I), R 1 , R 2 and R 3 are H, Cl or an alkyl group.
(Ⅱ) (Ⅱ)
상기 식(Ⅱ)에서, Me는 금속이온 이다.In the formula (II), Me is a metal ion.
무기계 항균제의 경우 제오라이트, 실리카알루미나 등의 무기담체에 은, 구리, 아연 등과 같이 항균성이 뛰어난 금속이온을 치환시킨 것을 사용하게 되는데, 일반적으로 그 평균입경이 수 마이크로 이상으로 크고 입도분포의 폭도 넓기 때문에 미세한 중공사막에 혼합하여 방사할 경우 절사 등의 위험이 있을 수 있다. 따라서 무기계 항균제를 사용하는 경우에는 평균입경이 작은 제품을 선택하여 사용하여야 한다. 무기계 항균제로써는 일반적으로 많이 사용하는 은계 제오라이트 등이 사용될 수 있다.In the case of inorganic antimicrobial agents, inorganic carriers such as zeolite and silica alumina are substituted with metal ions having excellent antimicrobial properties such as silver, copper, and zinc. Generally, the average particle diameter is several microns or more and the particle size distribution is wide. Mixing and spinning in a fine hollow fiber membrane may cause the risk of cutting off. Therefore, in case of using inorganic antimicrobial agent, the product with small average particle diameter should be selected and used. As the inorganic antimicrobial agent, silver zeolite, which is generally used, can be used.
본 발명에서 항균 중공사막내 잔존하는 항균제의 함량은 중공사막 전체 중량 대비 0.01 내지 3 중량%가 적당하다. 항균제의 함량이 이보다 높을 경우 인체에 유해한 항균제의 용출량이 증가되어 사용용도에 따라서 문제를 일으킬 위험성이 있고, 이보다 적은 경우에는 항균성능이 기대에 못 미치게 된다.In the present invention, the amount of the antimicrobial agent remaining in the antimicrobial hollow fiber membrane is suitably 0.01 to 3% by weight relative to the total weight of the hollow fiber membrane. If the content of the antimicrobial agent is higher than this, the amount of the antimicrobial agent harmful to the human body is increased, and there is a risk of causing problems depending on the intended use.
본 발명의 항균 중공사막의 제조방법은 크게 두가지로 나눌 수 있는데, 소수성 고분자, 유기용매 및 친수성 화합물로 구성된 방사도프와 내부응고액을 2중 관형노즐로 공기 중으로 방사한 후 외부응고액으로 응고시켜 중공사막을 제조할 때, 상기 방사도프에 항균제를 첨가하는 것과 상기 내부응고액(core)에 항균제를 첨가하는 것으로 나눌 수 있다. 본 발명의 항균 중공사막 제조방법의 특징은 항균제를 중공사막에 고정시키기 위해서, 방사원액에 직접 항균제를 투입한다는 것이다. 항균제를 방사원액 제조시에 직접 첨가하는 경우, 막제조상에 추가되는 공정이 없으므로 제조공정이 매우 단순한 장점이 있다. 또한, 항균제의 분산성이 좋아지고, 최종적으로 항균제가 막을 형성하는 소수성 고분자에 강하게 고착되게 되므로, 막을 사용할 때 항균제가 투과수에 씻겨 나가지 않게 되는 잇점이 있다. 항균제가 투과수에 씻겨 나가게 되면, 막의 잔존 항균제 함량이 낮아지므로 막의 항균성이 떨어지게 되고, 인체에 유해한 항균제 성분이 투과수에 포함되게 되어 정수기용 중공사막에 사용될 경우 문제를 일으킬 위험성이 있다. 본 발명의 제조방법에 의해 제조된 항균 중공사막은 일반 수도수를 5,000L/m2투과 사용한 후까지 중공사막 내의 잔존 항균제 함량이 초기 함량의 70% 이상을 유지하였다.The antimicrobial hollow fiber membrane manufacturing method of the present invention can be largely divided into two types, the spinning dope and the internal coagulating solution composed of hydrophobic polymer, organic solvent and hydrophilic compound are spun into the air with a double tubular nozzle and then solidified with external coagulant. When preparing the hollow fiber membrane, it can be divided into adding an antimicrobial agent to the spinning dope and adding an antimicrobial agent to the internal coagulation (core). A feature of the antimicrobial hollow fiber membrane manufacturing method of the present invention is that the antimicrobial agent is directly added to the spinning stock solution in order to fix the antimicrobial agent to the hollow fiber membrane. When the antimicrobial agent is added directly at the time of manufacture of the spinning stock solution, there is no process added to the film preparation, so the manufacturing process is very simple. In addition, since the dispersibility of the antimicrobial agent is improved, and finally the antimicrobial agent is strongly adhered to the hydrophobic polymer forming the membrane, the antimicrobial agent is not washed out in the permeated water when the membrane is used. When the antimicrobial agent is washed off in the permeate, the residual antimicrobial content of the membrane is lowered, so that the antimicrobial activity of the membrane is lowered, and the antimicrobial agent harmful to the human body is included in the permeate and there is a risk of causing problems when used in the hollow fiber membrane for water purifier. In the antimicrobial hollow fiber membrane prepared by the production method of the present invention, the residual antimicrobial content in the hollow fiber membrane was maintained at 70% or more of the initial content until after 5,000 L / m 2 permeation of the general tap water.
먼저 방사도프에 항균제를 첨가하는 경우, 막을 형성하는 상기 소수성 고분자를 유기용매에 용해시킨 다음 여기에 상기 친수성 화합물과 항균제를 첨가하여 방사 도프(dope)를 제조한다. 항균제를 방사 도프 제조시에 직접 첨가하기 위해서는 방사 도프에 항균제가 안정하게 용해되어야 한다. 본 발명에서는 이를 위해서 방사 도프의 제조 온도를 40 내지 140℃로 하였는데, 방사 도프의 제조 온도가 40℃이하일 경우에는 방사 도프의 안정성이 떨어져서 투명성이 낮아지고, 140℃이상일 경우는 친수성 화합물 또는 항균제가 변성을 일으켜서 중공사막의 최종 물성이 변하게 된다. 방사 도프의 안정성을 평가하기 위하여는 방사 도프의 흡광도를 측정하였는데, UV-VIS 스펙트로포토메터( spectrophotometer)로 측정시 파장 450nm에서의 흡광도가 0.5이하일 경우 안정하다고 판단하였다. 유기용매로는 m-크레졸, 클로로벤젠, N-메틸-2-피롤리돈, 디메틸설폭사이드, 디메틸아세트아마이드, 디메틸포름아마이드 및/또는 이들의 혼합물 등을 사용한다. 방사 도프를 구성하는 고분자의 함랑은 10-25중량%, 친수성 화합물의 전체함량은 10-25중량%가 되도록 한다. 본 발명에서는 항균제를 방사 도프에 0.01 내지 5중량% 혼합하여 방사 도프를 제조하였다. 0.01중량%이하로 사용하는 경우는 목표했던 항균 효과를 얻을 수 없었고, 5중량%이상 사용하는 경우에는 도프내에 입자가 석출되어, 방사 시에 절사를 유발하고 중공사막의 균일도에도 영향을 미치게 된다. 내부 응고액으로는 상기 유기용매와 비용매의 혼합물 또는 비용매 또는 비용매의 혼합물을 사용한다. 비용매로는 물, 알콜, 글리콜 등이 사용될 수 있는데, 특히 에틸 알콜, 디에틸렌 글리콜, 물 등을 사용할 수 있다. 다음으로는 통상의 2중 관형노즐을 사용하여 상기 방사 도프와 내부응고액을 공기중으로 방사하고, 외부응고액에서 응고되어 막구조가 형성되고 수세 및 권취한 뒤 건조하여 항균성을 가진 중공사막을 제조한다.First, when the antimicrobial agent is added to the spinning dope, the hydrophobic polymer forming the film is dissolved in an organic solvent, and then the hydrophilic compound and the antimicrobial agent are added thereto to prepare a spinning dope. In order to add the antimicrobial agent directly in the manufacture of the spinning dope, the antimicrobial agent must be stably dissolved in the spinning dope. In the present invention, for this purpose, the manufacturing temperature of the spinning dope is set to 40 to 140 ℃, when the manufacturing temperature of the spinning dope is 40 ℃ or less, the stability of the spinning dope is lowered, the transparency is lowered, when the hydrophilic compound or antimicrobial agent is 140 ℃ or more It causes denaturation and changes the final physical properties of the hollow fiber membranes. In order to evaluate the stability of the radiation dope was measured the absorbance of the radiation dope, it was determined that the absorbance at the wavelength of 450nm or less when measured by UV-VIS spectrophotometer (0.5) or less. As the organic solvent, m-cresol, chlorobenzene, N-methyl-2-pyrrolidone, dimethyl sulfoxide, dimethylacetamide, dimethylformamide and / or mixtures thereof are used. The content of the polymer constituting the spinning dope is 10-25% by weight, and the total content of the hydrophilic compound is 10-25% by weight. In the present invention, the antimicrobial agent was mixed with 0.01 to 5% by weight of the spinning dope to prepare a spinning dope. If it is used at 0.01% by weight or less, the desired antimicrobial effect could not be obtained. If it is used at 5% by weight or more, particles precipitate in the dope, causing cutting during spinning and affecting the uniformity of the hollow fiber membrane. As the internal coagulating solution, a mixture of the organic solvent and the nonsolvent or a mixture of the nonsolvent or the nonsolvent is used. As the non-solvent, water, alcohols, glycols and the like can be used, in particular ethyl alcohol, diethylene glycol, water and the like. Next, the spinning dope and the internal coagulating solution are spun into the air by using a conventional double tubular nozzle, and solidified in the external coagulating solution to form a membrane structure, washed with water, and then dried to prepare a hollow fiber membrane having antibacterial properties. do.
내부응고액(core)에 항균제를 첨가하여 항균 중공사막을 제조하는 경우, 막을 형성하는 상기 소수성 고분자와 상기 친수성 화합물을 유기용매에 용해시켜 방사 도프를 제조한 다음, 상기 내부응고액에 항균제와 분산성 증대를 위한 금속염을 첨가하여 내부응고액을 제조한다. 항균성이 요구되는 중공사막은 내오염성 또는 내구성이 문제가 되는 용도에 사용되므로, 그 구조는 대부분 외표면에 치밀한 구조를 가지고 내부는 지지층의 역할을 하는 비대칭 구조를 가지고 있다. 이러한 구조를 가지는 막을 제조할 때, 내부응고액에 항균제를 혼합할 경우, 항균제는 막이 형성되는 과정에서 막의 내부로부터 외부로 이동하면서, 막 내부에 견고하게 고정되게 된다. 항균제를 중공사막에 적용하기 위해서는 막제조공정에서의 안정성, 중공사막 재질과의 상용성, 막의 물성에 미치는 영향, 내구성, 분산성 등을 고려해야 한다. 항균제는 일반적으로 내부응고액으로 사용하는 용액에 녹지 않으므로, 분산상으로 존재하게 되는데, 분산입자의 크기가 클 경우 방사성이 떨어지고 균일한 막제조에 불리하다. 따라서, 본 발명에서는 항균제의 분산성을 높이기 위하여, 물에 대한 용해성을 증대시키는 효과를 가지는 금속염을 사용하였다. 금속염으로는 알칼리 금속염 또는 알칼리 토금속염이 사용될 수 있다. 내부응고액 조성액 중에 포함된 알칼리 금속염 또는 알칼리 토금속염의 함량이 0.01-5 중량%가 되도록 금속염을 내부응고액에 투입하는 것이 바람직 하다. 본 발명에서는 항균제를 내부응고액에 0.01 내지 5중량% 혼합하여 내부응고액을 제조하였다. 0.01중량% 미만으로 사용하는 경우는 목표했던 항균 효과를 얻을 수 없었고, 5중량%를 초과 사용하는 경우에는 분산성이 떨어지게 된다. 다음으로는 통상의 2중 관형노즐을 사용하여 방사도프와 상기 내부응고액을 공기중으로 방사하고, 외부응고액에서 응고되어 막구조가 형성되고 수세 및 권취한 뒤 건조하여 항균성을 가진 중공사막을 제조한다.When an antimicrobial hollow fiber membrane is prepared by adding an antimicrobial agent to an internal coagulation solution (core), the hydrophobic polymer and the hydrophilic compound forming the membrane are dissolved in an organic solvent to prepare a spinning dope, and then the anticoagulant and powder are added to the internal coagulation solution. Internal coagulating solution is prepared by adding a metal salt for increasing acidity. Since the hollow fiber membranes that require antimicrobial properties are used in applications where fouling resistance or durability is a problem, most of the structures have a dense structure on the outer surface and have an asymmetric structure inside serving as a support layer. When preparing a membrane having such a structure, when the antimicrobial agent is mixed with the internal coagulating solution, the antimicrobial agent is firmly fixed to the inside of the membrane while moving from the inside of the membrane to the outside in the process of forming the membrane. In order to apply the antimicrobial agent to the hollow fiber membrane, the stability in the membrane manufacturing process, compatibility with the material of the hollow fiber membrane, the effect on the properties of the membrane, durability, dispersibility, etc. should be considered. Since the antimicrobial agent generally does not dissolve in the solution used as the internal coagulating solution, the antimicrobial agent is present in a dispersed phase. When the size of the dispersed particles is large, the antimicrobial agent is inferior in radioactivity and disadvantageous for uniform film production. Therefore, in the present invention, in order to increase the dispersibility of the antimicrobial agent, a metal salt having an effect of increasing the solubility in water was used. Alkali metal salts or alkaline earth metal salts may be used as the metal salt. The metal salt is preferably added to the internal coagulation solution so that the content of the alkali metal salt or alkaline earth metal salt contained in the internal coagulation solution composition solution is 0.01-5% by weight. In the present invention, the anticoagulant was mixed with the internal coagulation solution in an amount of 0.01 to 5% by weight to prepare an internal coagulation solution. In the case of using less than 0.01% by weight, the target antibacterial effect could not be obtained, when using more than 5% by weight, the dispersibility is inferior. Next, the spinning dope and the inner coagulating solution are spun into the air by using a conventional double tubular nozzle, and the coagulated liquid is formed in the outer coagulating solution to form a membrane structure, washed with water, wound up and dried to produce a hollow fiber membrane having antibacterial properties. do.
이하 실시예를 통하여 본 발명을 더욱 구체적으로 살펴본다. 그러나 본 발명이 아래 실시예에만 한정되는 것은 아니다.Hereinafter, the present invention will be described in more detail with reference to the following examples. However, the present invention is not limited only to the following examples.
실시예 1Example 1
폴리설폰 수지(P-3500 : 아모코 회사제품) 16중량%, 폴리비닐피롤리돈 11중량%, 폴리에틸렌글리콜 4중량% 및 아연피리딘씨올 화합물(Zinc Omadine : OLIN사 제품) 1중량%를 디메틸아세트아마이드 68중량%에 투입한 후 교반, 용해시켜 투명한 방사 도프를 제조하였다. 방사 도프의 제조 온도는 80℃로 하였다. 내부응고액은 물 30중량%에 디에틸렌글리콜 70중량%를 첨가하여 제조하였다. 상기 방사 도프와 내부응고액을 통상의 2중 관형노즐을 통하여 공기중에 방사하고, 외부응고액이 있는 응고조에서 응고시킨 후, 세정, 권취하여 중공사막을 제조하였다. 이때 외부응고액으로는 물을 사용하였다. 제조된 중공사막을 막면적이 0.5m2이 되도록 번들링하여 건조하고, ABS재질로 된 케이스에 넣고, 폴리우레탄 접착제를 사용하여 포팅하여 모듈을 제조하였다.16% by weight of polysulfone resin (P-3500: Amoco Co., Ltd.), 11% by weight of polyvinylpyrrolidone, 4% by weight of polyethylene glycol, and 1% by weight of zinc pyridinethiol compound (Zinc Omadine: manufactured by OLIN) 68 wt% of acetamide was added, followed by stirring and dissolution to prepare a transparent spinning dope. The manufacturing temperature of spinning dope was 80 degreeC. The internal coagulation solution was prepared by adding 70% by weight of diethylene glycol to 30% by weight of water. The spinning dope and the internal coagulating solution were spun into air through a conventional double-tubular nozzle, and coagulated in a coagulation bath with an external coagulating solution, followed by washing and winding to prepare a hollow fiber membrane. At this time, water was used as the external coagulant. The prepared hollow fiber membrane was bundled and dried so as to have a membrane area of 0.5 m 2 , placed in an ABS material case, and potted using a polyurethane adhesive to prepare a module.
실시예 2Example 2
폴리설폰 수지(P-3500 : 아모코 회사제품) 16중량%, 폴리비닐피롤리돈 11중량% 및 폴리에틸렌글리콜 4중량%를 디메틸아세트아마이드 69중량%에 투입한 후 교반, 용해시켜 투명한 방사도프를 제조하였다. 내부응고액으로는 0.1몰 농도의LiBr 수용액 30중량%에 디에틸렌글리콜 69중량%와 항균제로서 아연피리딘씨올 화합물(Zinc Omadine : OLIN사 제품) 1중량%를 첨가하여 제조하였다. 상기 방사도프와 내부응고액을 통상의 2중 관형노즐을 통하여 공기중에 방사하고, 외부응고액이 있는 응고조에서 응고시킨 후, 세정, 권취하여 중공사막을 제조하였다. 이때 외부응고액으로는 물을 사용하였다. 제조된 중공사막을 막면적이 0.5㎡이 되도록 번들링하여 건조하고, ABS재질로 된 케이스에 넣고, 폴리우레탄 접착제를 사용하여 포팅하여 모듈을 제조하였다.16 wt% of polysulfone resin (P-3500: Amoko Co., Ltd.), 11 wt% of polyvinylpyrrolidone, and 4 wt% of polyethylene glycol were added to 69 wt% of dimethylacetamide, followed by stirring and dissolving. Prepared. The internal coagulation solution was prepared by adding 69% by weight of diethylene glycol and 1% by weight of a zinc pyridinethiol compound (Zinc Omadine: manufactured by OLIN) as an antibacterial agent to 30% by weight of a 0.1 mole LiBr aqueous solution. The spinning dope and the internal coagulating solution were spun into air through a conventional double tubular nozzle, and coagulated in a coagulation bath with an external coagulating solution, followed by washing and winding to prepare a hollow fiber membrane. At this time, water was used as the external coagulant. The prepared hollow fiber membrane was bundled and dried to have a membrane area of 0.5 m 2, put in a case made of ABS material, and potted using a polyurethane adhesive to prepare a module.
비교실시예 1Comparative Example 1
방사도프 제조시 항균제로서 아연피리딘씨올 화합물(Zinc Omadine : OLIN사 제품)을 투입하지 않고 디메틸아세트아마이드 69중량%를 투입한 것을 제외하고는 실시예 1과 동일한 방법으로 중공사막 및 모듈을 제조하였다.A hollow fiber membrane and a module were prepared in the same manner as in Example 1, except that 69 wt% of dimethylacetamide was added without adding zinc pyridinethiol compound (Zinc Omadine: manufactured by OLIN) as an antimicrobial agent. .
비교실시예 2Comparative Example 2
실시예 2의 내부응고액 대신에 물 30중량%에 디에틸렌글리콜 70중량%를 첨가하여 제조한 내부응고액(항균제 함유 안됨)을 사용한 것을 제외하고는 실시예 2와 동일한 방법으로 중공사막 및 모듈을 제조하였다.Hollow fiber membrane and module in the same manner as in Example 2 except for using the internal coagulation solution (containing no antibacterial agent) prepared by adding 70% by weight of diethylene glycol to 30% by weight of water instead of the internal coagulation solution of Example 2. Was prepared.
- 실험예 1 : 항균력 및 잔존항균제 시험 -Experimental Example 1 Antibacterial Activity and Remaining Antibiotic Test
상기 제조된 중공사막의 항균력과 잔존항균제의 함량을 다음과 같이 평가하였다. 중공사 모듈에 원수(1,500CFU/ml)를 충진하고 37℃ 항온배양기에서 24시간 배양한 후 충진수의 일반세균농도를 측정하였다. 잔존항균제의 함량은 항균제에 포함된 금속이온의 함량을 원소흡광기를 이용하여 측정 하였다. 측정 결과를 표1에 나타내었다. 항균제를 포함한 중공사막은 세균수가 감소하였으나, 항균제를 포함하지 않은 막은 세균이 증식함을 알 수 있다.The antimicrobial activity and content of the remaining antimicrobial agent of the prepared hollow fiber membrane was evaluated as follows. The hollow fiber module was filled with raw water (1,500 CFU / ml) and incubated in a 37 ° C. incubator for 24 hours, and then the general bacterial concentration of the filling was measured. Residual antimicrobial content was measured by using an element absorber to determine the content of metal ions included in the antimicrobial agent. The measurement results are shown in Table 1. The hollow fiber membrane containing the antimicrobial agent decreased the number of bacteria, but the membrane without the antimicrobial agent showed that the bacteria proliferated.
- 실험예 2 : 누적유량 시험 -Experimental Example 2 Cumulative Flow Rate Test
상기 제조된 중공사 모듈을 1kg/c㎡의 압력으로 수투과 시험을 실시하여 누적유량이 5,000L가 되었을 때의 순간유량을 비교하였다. 항균제를 포함한 막의 경우, 항균효과에 의해 내오염성이 좋아져서 순간유량이 우수하나, 항균제를 포함하지 않은 막은 순간유량이 감소함을 알 수 있다.The hollow fiber module prepared above was subjected to a water permeation test at a pressure of 1 kg / cm 2 to compare the instantaneous flow rates when the cumulative flow rate reached 5,000 liters. In the case of the membrane containing the antimicrobial agent, the instantaneous flow rate is excellent due to the anti-microbial effect, but it can be seen that the instantaneous flow rate is reduced in the membrane without the antimicrobial agent.
- 실험예 3 : 방사성 및 방사도프 특성 시험 -Experimental Example 3 Radioactive and Radiation Doping Characteristic Test
중공사 제조시의 방사성과 방사도프 특성을 비교 평가 하였다. 방사도프 특성은 파장 450nm에서의 흡광도를 UV-VIS 스펙트로포토메터(spectrophotometer)를 이용해 측정하였는데, 이는 방사도프의 안정성을 나타내는 기준으로 사용된다.We compared and evaluated the radioactivity and spinning dope characteristics of hollow fiber manufacturing. Radiation dope properties were measured by using a UV-VIS spectrophotometer (absorbance at wavelength 450nm), which is used as a reference indicating the stability of the radiation dope.
- 실험예 4 : 잔류항균제 시험 -Experimental Example 4: residual antimicrobial test
실험예 2의 누적유량 시험 전후 중공사막에 존재하는 항균제의 함량을 비교하여 항균제의 내구성을 평가하였다. 방사 도프 제조시의 높은 온도가 항균제와 막을 형성하는 고분자사이의 물리화학적 결합을 강하게 하여 최종 제품의 사용시 항균제의 용출을 방지함으로써 지속적인 항균효과를 가질 수 있도록 함을 알 수 있다.The durability of the antimicrobial agent was evaluated by comparing the content of the antimicrobial agent in the hollow fiber membrane before and after the cumulative flow rate test of Experimental Example 2. It can be seen that the high temperature in the preparation of the spinning dope strengthens the physicochemical bond between the antimicrobial agent and the polymer forming the film, thereby preventing the dissolution of the antimicrobial agent in the use of the final product, thereby having a continuous antimicrobial effect.
본 발명의 방법에 따라 제조된 중공사막은 항균성이 우수하여 종래의 분리막에 비해 세균억제성능이 월등히 향상되었고, 내오염성이 우수하여 사용수명이 연장될 수 있다. 따라서, 본 발명의 항균 중공사막은 우수한 균제거성능과 다량의 투과량을 필요로 하는 가정용 정수기, 산업용, 의료용 정수장치에 유용하다.The hollow fiber membranes prepared according to the method of the present invention have excellent antibacterial properties, significantly improved bactericidal properties compared to the conventional separation membranes, and have excellent fouling resistance, thereby extending the service life. Therefore, the antimicrobial hollow fiber membrane of the present invention is useful for household water purifiers, industrial and medical water purifiers that require excellent bacteria removal performance and a large amount of permeation.
Claims (13)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020030009956A KR100846395B1 (en) | 2003-02-18 | 2003-02-18 | Antimicrobial hollow fiber membrane and method of preparing the same |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020030009956A KR100846395B1 (en) | 2003-02-18 | 2003-02-18 | Antimicrobial hollow fiber membrane and method of preparing the same |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20040074362A true KR20040074362A (en) | 2004-08-25 |
KR100846395B1 KR100846395B1 (en) | 2008-07-15 |
Family
ID=37361100
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020030009956A KR100846395B1 (en) | 2003-02-18 | 2003-02-18 | Antimicrobial hollow fiber membrane and method of preparing the same |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR100846395B1 (en) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2016072634A1 (en) * | 2014-11-03 | 2016-05-12 | 롯데케미칼 주식회사 | Method for preparing polymer resin composition for producing filtration membrane having improved hydrophilicity and mechanical strength |
GB2573404A (en) * | 2018-05-03 | 2019-11-06 | Pak Vitae Private Ltd | Hollow fiber membrane for filtration of liquids |
CN110711496A (en) * | 2019-10-09 | 2020-01-21 | 东莞东阳光科研发有限公司 | Anti-biological-pollution porous membrane and preparation method and application thereof |
KR20200076241A (en) * | 2018-12-19 | 2020-06-29 | 주식회사 아이큐브글로벌 | Method for producing a membrane with metal nano-particles and product using the membrane |
WO2020239452A1 (en) * | 2019-05-27 | 2020-12-03 | Unilever N.V. | Fibre comprising organosilane for purification of liquids |
KR20210075770A (en) | 2019-12-13 | 2021-06-23 | (주)필코아 | Method for preparing anti-microbial hollow fiber membrane, the prepared anti-microbial hollow fiber membrane and the water purifier filter comprising thereof |
CN115726052A (en) * | 2022-11-26 | 2023-03-03 | 上海工程技术大学 | Biodegradable antibacterial fiber, preparation method thereof and fabric prepared from biodegradable antibacterial fiber |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH05245349A (en) * | 1991-11-06 | 1993-09-24 | Nitto Denko Corp | Antibacterial liquid separation membrane and its production |
JPH0648824U (en) * | 1992-12-17 | 1994-07-05 | 宇部興産株式会社 | Hydrophilic porous hollow fiber membrane |
KR0137384B1 (en) * | 1994-12-30 | 1998-04-25 | 박흥기 | Reverse osmosis module using antibiotic permeation water collection tube |
JPH08206467A (en) * | 1995-02-07 | 1996-08-13 | Mitsubishi Rayon Co Ltd | Counter contamination preventing membrane module |
JPH11221451A (en) | 1998-02-06 | 1999-08-17 | Nok Corp | Separation membrane containing antibacterial material and its production |
WO2000000268A1 (en) | 1998-06-29 | 2000-01-06 | Microban Products Company | Antimicrobial semi-permeable membranes |
KR20040070939A (en) * | 2003-02-05 | 2004-08-11 | 주식회사 코오롱 | An anti-microbiological hollow fiber membrane, and a process of preparing for the same |
-
2003
- 2003-02-18 KR KR1020030009956A patent/KR100846395B1/en active IP Right Grant
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2016072634A1 (en) * | 2014-11-03 | 2016-05-12 | 롯데케미칼 주식회사 | Method for preparing polymer resin composition for producing filtration membrane having improved hydrophilicity and mechanical strength |
GB2573404A (en) * | 2018-05-03 | 2019-11-06 | Pak Vitae Private Ltd | Hollow fiber membrane for filtration of liquids |
GB2573404B (en) * | 2018-05-03 | 2021-03-31 | Pak Vitae Private Ltd | Hollow fiber membrane for filtration of liquids |
US11148100B2 (en) | 2018-05-03 | 2021-10-19 | Pak Vitae (Private) Limited | Hollow fiber membrane for filtration of liquids |
EP3563928B1 (en) * | 2018-05-03 | 2023-07-05 | Pak Vitae (Private) Limited | Hollow fiber membrane for filtration of liquids |
KR20200076241A (en) * | 2018-12-19 | 2020-06-29 | 주식회사 아이큐브글로벌 | Method for producing a membrane with metal nano-particles and product using the membrane |
WO2020239452A1 (en) * | 2019-05-27 | 2020-12-03 | Unilever N.V. | Fibre comprising organosilane for purification of liquids |
CN113766960A (en) * | 2019-05-27 | 2021-12-07 | 联合利华知识产权控股有限公司 | Fibers comprising organosilanes for liquid purification |
CN110711496A (en) * | 2019-10-09 | 2020-01-21 | 东莞东阳光科研发有限公司 | Anti-biological-pollution porous membrane and preparation method and application thereof |
KR20210075770A (en) | 2019-12-13 | 2021-06-23 | (주)필코아 | Method for preparing anti-microbial hollow fiber membrane, the prepared anti-microbial hollow fiber membrane and the water purifier filter comprising thereof |
CN115726052A (en) * | 2022-11-26 | 2023-03-03 | 上海工程技术大学 | Biodegradable antibacterial fiber, preparation method thereof and fabric prepared from biodegradable antibacterial fiber |
Also Published As
Publication number | Publication date |
---|---|
KR100846395B1 (en) | 2008-07-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR102195307B1 (en) | Colloidal antibacterial and anti-bioadhesive coating on the surface | |
EP1098691B1 (en) | Antimicrobial semi-permeable membranes | |
US9364797B2 (en) | High flux hollow fiber ultrafiltration membranes and process for the preparation thereof | |
CN102573501A (en) | Nano silver-zinc oxide composition | |
KR20020000715A (en) | Porous hollow fiber membranes and method of making the same | |
MX2011003082A (en) | Porous membrane, process for producing porous membrane, process for producing clarified liquid, and porous-membrane module. | |
JP2001070767A (en) | Ultrafiltration membrane and production of the same and dope composition to be used for the same | |
KR100846395B1 (en) | Antimicrobial hollow fiber membrane and method of preparing the same | |
JP7046867B2 (en) | Hollow fiber membrane for filtering liquids | |
KR20150069786A (en) | Good with Antiviral and antibacterial Filter cartridgeand method of manufacturing them | |
MX2011005333A (en) | Antimicrobial device and materials for fluid treatment. | |
KR102345697B1 (en) | Method for preparing anti-microbial hollow fiber membrane, the prepared anti-microbial hollow fiber membrane and the water purifier filter comprising thereof | |
EP2038226A1 (en) | Dihalogeno-hydroxydiphenylether as antimicrobials in water treatment | |
EP1140333B1 (en) | Microporous flat, capillary or tubular membrane and method of manufacturing the same | |
KR20160080537A (en) | Cartridge filter for water purifier, Preparing method thereof and the Cartridge for water purifier containing the same | |
KR20040070939A (en) | An anti-microbiological hollow fiber membrane, and a process of preparing for the same | |
KR101074373B1 (en) | Method for preparing hollow fiber membrane with high anti-microbiological property | |
KR20050100833A (en) | Antimicrobial braid-reinforced hollow fiber membrane and method of preparing the same | |
JP2009011913A (en) | Membrane separation method and membrane separation apparatus | |
KR100646651B1 (en) | A filter of hollow fiber membrane used in purifing water | |
WO2019172077A1 (en) | Hollow-fiber membrane and method for producing hollow-fiber membrane | |
KR101283738B1 (en) | Asymmetric ultrafiltration and microfiltration membranes containing chitosan molecules and the method for preparation thereof | |
KR20010100304A (en) | Producing method of the reverse osmosis membrane of drying type | |
KR101537446B1 (en) | Porous complex media, method of Porous complex media and Filter cartridge using that | |
KR20240043863A (en) | Positively charged hollow fiber membrane and manufacturing method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20130620 Year of fee payment: 6 |
|
FPAY | Annual fee payment |
Payment date: 20140701 Year of fee payment: 7 |
|
FPAY | Annual fee payment |
Payment date: 20160630 Year of fee payment: 9 |
|
FPAY | Annual fee payment |
Payment date: 20170703 Year of fee payment: 10 |
|
FPAY | Annual fee payment |
Payment date: 20180702 Year of fee payment: 11 |
|
FPAY | Annual fee payment |
Payment date: 20190701 Year of fee payment: 12 |